Revvity Developing Automated Platform for Tuberculosis Testing
Revvity is developing the T-SPOT A201, an automated platform for latent tuberculosis testing in high-volume labs, with planned launch in 2027 pending regulatory approval.
Read More
Search Results for: liver disease
Ibex Earns European Certification for Complete Breast Pathology AI Suite
Ibex Medical Analytics has received IVDR certification for its breast cancer diagnostic tools, completing regulatory approval for ER, PR, and Ki67 tests, according to a company press release.
Read More
Alamar Gains Rights to Develop Clinical Alzheimer’s Blood Tests Using ALZpath Antibody
ALZpath and Alamar Biosciences have expanded their partnership, granting Alamar commercial rights to use ALZpath’s pTau217 antibody in clinical blood tests for Alzheimer’s disease.
Read More
Countable Labs Launches Program Connecting Researchers With Single-Molecule PCR Services
The program connects researchers with certified laboratories offering single-molecule PCR testing, technical support, and bioinformatics expertise.
Read More
Myriad Genetics Launches New Four-in-One Prenatal Genetic Screen
Myriad Genetics has launched the FirstGene Multiple Prenatal Screen, a test that combines four prenatal genetic screens from a single blood draw as early as eight weeks gestation, according to the company.
Read More